Kei Tolliver
Sucampo Pharmaceuticals has announced Kei Tolliver - executive vice president at S&R Technology Holdings - has been elected to its board.
CEO Dr. Ryuji Ueno said: “Kei brings to Sucampo’s Board a deep knowledge of our company’s products as well as global experience. We believe that this expertise will provide value to Sucampo and our shareholders as we focus on the growth of our business and the further development of our pipeline.”